Company profile: Immucor
1.1 - Company Overview
Company description
- Provider of transfusion and transplantation diagnostic products, including serology reagents, instruments, and molecular solutions for donor-recipient compatibility and pre-transfusion testing; transplant tools to guide recipient care and monitor rejection; platelet antibody screening and antigen identification; coagulation assays; HLA donor screening; and NGS HLA typing kits and software.
Products and services
- Typing Solutions: Delivers NGS-based HLA typing kits and software enabling transplant labs to report high-quality HLA typing results with precision and reliability
- Transfusion: Supplies clinical-grade serology reagents, instruments, and molecular products to ensure donor-recipient compatibility and deliver accurate, reproducible pre-transfusion test results
- Transplant: Offers diagnostic-grade products to determine the best path forward for transplant recipients and monitor for possible post-transplant rejection
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Immucor
Velano Vascular
HQ: United States
Website
- Description: Provider of needle-free blood draw devices that leverage existing peripheral IV lines to enhance inpatient blood collection and vascular access. Its FDA-approved PIVO devices facilitate frequent, high-quality blood draws, aiming to reduce pain, risk, preanalytical errors, needlestick injuries, IV replacements, and multiple needlesticks.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Velano Vascular company profile →
Exactus
HQ: United States
Website
- Description: Provider of first-of-its-kind handheld point-of-care diagnostic devices that analyze specific markers in the blood, currently being developed for commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Exactus company profile →
Disc Medicine
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies for hematologic diseases and rare blood disorders, including Bitopertin, an oral GlyT1 inhibitor for erythropoietic porphyrias and abnormal erythropoiesis; DISC-0974, an injectable monoclonal antibody targeting hemojuvelin (HJV) to suppress hepcidin for anemias of inflammation; and DISC-3405, an injectable monoclonal antibody inhibiting TMPRSS6 to increase hepcidin for polycythemia vera and iron overload.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Disc Medicine company profile →
Daxor
HQ: United States
Website
- Description: Provider of medical instrumentation and biotechnology solutions, offering the BVA-100 diagnostic blood test that quantifies blood volume status and composition to aid management of medical and surgical conditions, and clinical education and support for effective use of the BVA-100 in clinical settings.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Daxor company profile →
YourBio Health
HQ: United States
Website
- Description: Provider of virtually painless blood collection solutions and services, simplifying blood sampling and testing. Offers TAP Micro Select for clinical-grade sampling and TAP Micro (investigational in the US, CE marked), both using HALO Technology bladeless microneedle arrays. Provides devices and customizable kitting, fulfillment, and sample tracking for decentralized clinical trials, plus turnkey wellness testing with lab integration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full YourBio Health company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Immucor
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Immucor
2.2 - Growth funds investing in similar companies to Immucor
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Immucor
4.2 - Public trading comparable groups for Immucor
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →